Announcements Trials
Browse Landscape

Phase

Phase 2 46Phase 1 11Phase 1/2 6Phase NA 2Phase 4 2Phase 2/3 2Phase 3 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 1Head & Neck 1Endocrine 1

Conditions

Thyroid Neoplasms 1Thyroid Cancer, Papillary 1Neoplasms 1Neoplasm Metastasis 1

Interventions

Exercise 418Blood Specimen Collection 317Standard of Care 295Surveys and Questionnaires 241Radiosurgery 239Magnetic Resonance Spectroscopy 232Educational Status 222Methods 219Radiotherapy 216Early Intervention, Educational 199Practice Guidelines as Topic 140Interviews as Topic 139Biopsy 125Surgical Procedures, Operative 119Drug Therapy 119Acupuncture Therapy 119Control Groups 115Therapeutics 100Palliative Care 97Resistance Training 93Counseling 88Saline Solution 87Magnetic Resonance Imaging 84Cyclophosphamide 83Cisplatin 73Radiofrequency Ablation 71Cognitive Behavioral Therapy 71Specimen Handling 70Radiotherapy, Intensity-Modulated 68Colonoscopy 65

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × OTHER × dabrafenib × Clear all
NCT04801966 2023-05-10

TAILOR

Peter MacCallum Cancer Centre, Australia

Phase NA Terminated
3 enrolled
Tumor-Agnostic

Neoplasms

NCT01534897 2017-03-15

Re-differentiation of Radioiodine-Refractory BRAF V600E-mutant Papillary Thyroid Carcinoma With GSK2118436

Massachusetts General Hospital

Phase NA Completed
10 enrolled 9 charts
EndocrineHead & Neck

Thyroid Cancer, Papillary, Neoplasm Metastasis, Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡